新型冠状病毒肺炎治疗中应关注肝损伤及防治中药概述
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

天津市科技支撑重点项目(JK1802)


The Treatment of Corona Virus Disease 19 (COVID-19) Should Focus on Liver Injury and the Overview of Prevention and Treatment of Traditional Chinese Medicines(TCMs)
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    较大比例的新型冠状病毒感染者在接受抗病毒治疗过程中出现了肝功能异常现象,进而导致脓毒症或感染性休克的发生,需引起临床工作者的关注。多年来,中医药在临床用于肝损伤保护方面发挥了重要作用,其功效得到了普遍的肯定。本文将从新型冠状病毒所致肝损伤的机制、病毒和药物所致肝损伤的病理变化以及常用防治肝损伤的中药及其制剂进行综述,以期为新型冠状病毒肺炎(NCP)患者的肝损伤防治提供参考支持。

    Abstract:

    A large proportion of patients with severe acute respiratory syndrome coronavirus 2 infection showed abnormal liver function during the antiviral treatment,which led to sepsis or septic shock,thus causing widespread concern among clinicians. Over the years,traditional Chinese medicines (TCMs) have played an important role in the clinical application of liver injury protection,and its efficacy has been widely recognized. The paper reviewed the mechanism of liver injury caused by 2019-nCoV,the pathological changes of liver injury caused by viruses and drugs,and the TCMs and preparations commonly used to prevent and cure liver injury,in order to provide reference support for the prevention and treatment of liver injury in patients with Novel Coronavirus Pneumonia (NCP).

    参考文献
    相似文献
    引证文献
引用本文

褚扬,周王谊,吴江,乔淼,王婉琦,马晓慧,周水平,郝海平.新型冠状病毒肺炎治疗中应关注肝损伤及防治中药概述[J].世界中医药,2020,(02).

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2020-02-14
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2020-02-17
  • 出版日期:
文章二维码